ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,337.00
2.00 (0.15%)
Last Updated: 09:31:34
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 0.15% 1,337.00 1,336.50 1,337.50 1,337.50 1,333.00 1,335.00 379,292 09:31:34
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.22 55.34B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,335p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.34 billion. Gsk has a price to earnings ratio (PE ratio) of 11.22.

Gsk Share Discussion Threads

Showing 26401 to 26422 of 34075 messages
Chat Pages: Latest  1063  1062  1061  1060  1059  1058  1057  1056  1055  1054  1053  1052  Older
DateSubjectAuthorDiscuss
02/5/2021
21:07
Simpleton who compares apples with pears. Oh dear indeed.
alex1621
02/5/2021
20:58
Oh dear...... :-(spud
spud
02/5/2021
19:59
It's not the same market, and it's not the same products ... it's the same sector. AZN are in different markets. It's not a like for like comparison. It's a differentiated product business, not a commodity product business.
alex1621
02/5/2021
19:50
Ok. So explain the AZN overachieve? Same market same product synergies.

spud

spud
02/5/2021
19:39
You do know. It would be no different ... because some events are simply out of a manager's control. Like a cruise ship CEO ... or a restaurant owner ... or a cinema operator ... during a pandemic.
alex1621
02/5/2021
19:11
I haven't a clue. What I do know is that he would have been proactive in pipeline investments and not relied on a single earner. spud
spud
02/5/2021
19:06
If Pascal Soriot took over GSK in early 2020 would Shingrix sales be as high or higher than 2019?
alex1621
02/5/2021
18:45
So how come AZN has just reported superb figures in their latest report while GSK just blame shifted?

I’ll give you a clue : Pascal.

spud

spud
02/5/2021
18:36
GSK has been hit by Covid, like many other businesses. So consumer, vaccines and pharma have underperformed. If the pandemic had not arisen the numbers would have been much better. So it's transitory, not a long term trend. The failure with Sanofi added to the negative sentiment. This too shall pass.
alex1621
02/5/2021
18:31
Only a fool would think this is sinking. Its just not been steered well at all
markbelluk
02/5/2021
18:24
A sinking ship ain’t worth as much as a floating .

Whatsup:)

whatsup32
02/5/2021
17:36
A rudderless ship ain't worth as much as one that is able go where it's pointed....spud
spud
02/5/2021
16:07
But 100 billion implies a 48% upside.
alex1621
02/5/2021
16:00
Sorry, billion. But given time EW might get there.
alex1621
02/5/2021
14:13
Ha - with Emma's performance it may be that 50 million is more likely.She is giving it a good go
watfordhornet
02/5/2021
14:05
£50M cap for each would be an impressive shrinkage of the company's worth even by the current management's standards :-)
cwa1
02/5/2021
13:36
Is it million cap or billion cap ?
abdullla
02/5/2021
13:05
If Elliot are American based they do not have to declare unless they reach/pass 5%.
beckers2008
02/5/2021
12:54
One interesting snippet from the Sunday Times article was the idea that both businesses post split would be valued around £50m cap, so £100m cap holding. Quite an uplift from today's share price
alex1621
02/5/2021
11:20
You are right, expect loads more as Elliott keeps stoking it

As for the disclosure issue, doesn’t matter how Elliott owns its stake, it has a duty to declare once it believes it to be over 3 percent. And there is also a provision in the Companies Act for GSK to serve notice on a party to disclose its holding whatever the level. Used to be a 212 notice now I think renumbered but provision is the same. And you can bet your bottom dollar that as soon as the FT article came out GSk would have served one and you can keep serving one as far as I am aware

daneswooddynamo
02/5/2021
10:03
My understanding was that ultimate holder ‘once they know their holding is above 3% they were obliged to notify regulator.

Otherwise anyone can instruct 100 banks to buy 1% of the target company and not notify anyone .

I’m not an expert , merely questioning

whatsup32
02/5/2021
09:45
If they've bought it via total return swaps then the only obligation would be on the banks on the other end of those swaps to notify their holdings (they will buy the stock to hedge their position) The trade will be split over a few banks, so no need for anyone to notify anything
williamcooper104
Chat Pages: Latest  1063  1062  1061  1060  1059  1058  1057  1056  1055  1054  1053  1052  Older